BAY-6096

BAY-6096 : Antagonist of ADRA2B

Structure

Information

  • ADRA2B
  • Antagonist
  • 100 nM

In Vitro Validations

Uniprot ID: P18089
Target Class: GPCR
Target SubClass: Adrenergic receptor
Potency: Ki
Potency Value: 21 nM
Potency Assay: Radioactive binding assay for human ADRA2B
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Alpha-2B adrenergic receptor, ADRA2RL1, ADRA2L1, A ...

DOI Reference: 10.1021/acs.jmedchem.2c01690

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Potency assay (off target): Selectivity within target family: Adrenergic receptor panel (IC50): ADRA1A (5.516 µM; 394- fold), ADRA1B (> 10 µM), ADRA1D (> 10 µM), ADRA2A (10 µM), ADRA2C (>11.83 µM), ADRB1 (> 10 µM), ADRB2 (> 10 µM), ADRB3 (> 10 µM). Selectivity outside target familyEurofins Panlabs panel (67 targets) at 10 µM: clean In-house kinase panel (22 kinases): human DDR2: IC50 = 1.4 µM, others IC50 > 20 µM
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating
In Model Organisms

SERP Comments:

A highly potent, selective and aqueous soluble antagonist of alpha2B suitable for cell-based and in vivo studies (via the intravenous route).

(last updated: 12 Apr 2024 )